Legal Representation
Attorney
Ajay A. Jagtiani
USPTO Deadlines
Next Deadline
2095 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-29)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 13, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 12, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 16, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 16, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 16, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 16, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents.
First Use Anywhere:
May 9, 2024
First Use in Commerce:
May 9, 2024
Class 042
Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays.
First Use Anywhere:
May 9, 2024
First Use in Commerce:
May 9, 2024
Classification
International Classes
040
042